Shepler Robert G's Form 4 filing
Akoya Biosciences, Inc. (AKYA) · filed Nov 18, 2021
- Accession no.
- 0001104659-21-141484
- Filed
- Nov 18, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $441.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shepler Robert GCIK 0001113663 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $11.85-$12.75. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F2
Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.85-$13.00. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.